Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson's Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2025-1-24

Curated date: 2024/03/17

Curator: Aishat

Revision editor(s): Scholastica, Aleru Divine, Victoria, Aishat

Subjects

Location of subjects
Japan
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Sleep Disorder Disturbances, Sleep,disturbances, sleep,parasomnia,sleep disorder,Sleep Disorders,Sleep Disturbance,sleep disturbance,Sleep Disturbances,sleep disturbances,Sleep Disorder,sleep Disorder
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
Rapid-eye-movement sleep behavior disorder (iRBD) patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with idiopathic rapid-eye-movement sleep behavior disorder (iRBD) diagnosed according to the International Classification of Sleep Disorders Criteria-Third Edition
Group 0 sample size Number of subjects in the control (unexposed) group
137
Group 1 sample size Number of subjects in the case (exposed) group
26
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
1 month

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Statistical test
ANCOM
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes


Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-1-24

Curated date: 2024/03/17

Curator: Aishat

Revision editor(s): Aishat, Aleru Divine

Source: Supplementary Table S2

Description: Read counts of genera normalized for 1 × 104 reads in controls and iRBD.

Abundance in Group 1: increased abundance in Rapid-eye-movement sleep behavior disorder (iRBD) patients

NCBI Quality ControlLinks
Akkermansia
Akkermansiaceae
Alistipes
Eubacterium coprostanoligenes
Rikenellaceae
Ruminococcus 2Ruminococcus 2
Ruminococcaceae UCG-005Ruminococcaceae UCG-005
Ruminococcaceae UCG-004Ruminococcaceae UCG-004
Family XIII AD3011 groupFamily XIII AD3011 group

Revision editor(s): Aishat, Aleru Divine